|
|
|
|
LEADER |
02818nam a2200577 i 4500 |
001 |
1196336547 |
003 |
OCoLC |
005 |
20200921080735.0 |
006 |
m o d f |
007 |
cr ||||||||||| |
008 |
200921m20209999dcua ob f000 0 eng c |
024 |
8 |
|
|a 41-359
|q (GPO jacket number)
|
040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d GPO
|d MvI
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a COM7
|
050 |
|
4 |
|a KF26
|b .F5693 2019
|
074 |
|
|
|a 1038-C (online)
|
086 |
0 |
|
|a Y 4.F 49:S.HRG.116-267
|
110 |
1 |
|
|a United States.
|b Congress.
|b Senate.
|b Committee on Finance,
|e author.
|
245 |
1 |
0 |
|a Drug pricing in America :
|b a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
|
264 |
|
1 |
|a Washington :
|b U.S. Government Publishing Office,
|c 2020-
|
300 |
|
|
|a 1 online resource (volumes) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a computer
|b c
|2 rdamedia.
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
490 |
1 |
|
|a S. hrg. ;
|v 116-267.
|
500 |
|
|
|a Access ID (govinfo): CHRG-116shrg41359.
|
500 |
|
|
|a "Serial no. 116-267."
|
500 |
|
|
|a "January 29, 2019"--Pt. 1.
|
500 |
|
|
|a GPO Cataloging Record Distribution Program (CRDP).
|
504 |
|
|
|a Includes bibliographical references.
|
511 |
0 |
|
|a "Hearing witnesses: Sego, Kathy, mother of a child with insulin-dependent diabetes, Madison, IN; Holtz-Eakin, Douglas, Ph.D., president, American Action Forum, Washington, DC; Miller, Mark, Ph.D., executive vice president of health care, Laura and John Arnold Foundation, Houston, TX; Bach, Peter B., M.D., director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY."--Pt. 1.
|
518 |
|
|
|a "Date of hearing: 2019-01-29"--Pt. 1.
|
588 |
|
|
|a Description based on online resource; title from PDF, pt. 1, title page (Govinfo website, viewed Sep. 18, 2020).
|
650 |
|
0 |
|a Drugs
|x Prices
|z United States.
|
650 |
|
0 |
|a Prescription pricing
|z United States.
|
650 |
|
0 |
|a Pharmaceutical services insurance
|z United States.
|
650 |
|
0 |
|a Medical policy
|z United States.
|
655 |
|
7 |
|a Legislative hearings.
|2 lcgft.
|
810 |
1 |
|
|a United States.
|b Congress.
|b Senate.
|t S. hrg. ;
|v 116-267.
|
856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo145123
|
907 |
|
|
|a .b61805956
|b cug
|c -
|d 201009
|e 230210
|
998 |
|
|
|a cug
|b 201009
|c m
|d a
|e -
|f eng
|g dcu
|h 0
|i 1
|
922 |
|
|
|a BIBCONEW
|
948 |
|
|
|a MARCIVE Overnight, in 2023.02
|
948 |
|
|
|a MARCIVE Over, 11/2020
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2023.02
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2020.11
|
995 |
|
|
|a Loaded with m2btab.msgov7 in 2020.10
|
989 |
|
|
|a Y 4.F 49:S.HRG.116-267
|d cuege
|e - -
|f - -
|g j
|h 0
|i 0
|j 216
|k 201009
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w US Gov Docs
|1 .i132810384
|